n,n-dimethylarginine has been researched along with pyrazolanthrone in 1 studies
Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (pyrazolanthrone) | Trials (pyrazolanthrone) | Recent Studies (post-2010) (pyrazolanthrone) |
---|---|---|---|---|---|
2,216 | 228 | 1,221 | 1,484 | 2 | 765 |
Protein | Taxonomy | n,n-dimethylarginine (IC50) | pyrazolanthrone (IC50) |
---|---|---|---|
Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 20.2 | |
TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 6.31 | |
Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | 0.72 | |
Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | 8 | |
Dual specificity protein kinase TTK | Homo sapiens (human) | 0.8987 | |
Mitogen-activated protein kinase 8 | Homo sapiens (human) | 0.921 | |
Mitogen-activated protein kinase 9 | Homo sapiens (human) | 1.0111 | |
Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 0.957 | |
Mitogen-activated protein kinase 10 | Homo sapiens (human) | 1.4193 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.15 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, X; Lu, W; Yuan, WX; Zhang, FQ | 1 |
1 other study(ies) available for n,n-dimethylarginine and pyrazolanthrone
Article | Year |
---|---|
Regulation of c-Jun N-Terminal Protein Kinase (JNK) Pathway in Apoptosis of Endothelial Outgrowth Cells Induced by Asymmetric Dimethylarginine.
Topics: Anthracenes; Apoptosis; Arginine; Cell Proliferation; Cell Survival; Endothelial Cells; Flow Cytometry; Fluorescence; Humans; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Neovascularization, Physiologic; Phosphorylation; Protein Kinase Inhibitors; Staining and Labeling | 2017 |